Watchlist Price Alert

Merrimack Pharmaceuticals... (MACK)

NASDAQ: MACK · Real-Time Price · USD

15.14

0.01 (0.07%)

At close: May 17, 2024, 7:59 PM

Merrimack Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-1.18M	-1.54M	-2.46M	-3.03M	-21.27M	-60.94M	-58.72M	-153.52M
Depreciation & Amortization	n/a	n/a	n/a	n/a	2.23M	4.07M	5.22M	6.25M
Stock-Based Compensation	160K	71K	397K	1.72M	2.37M	n/a	12.79M	14.87M
Other Working Capital	84K	149K	2.19M	764K	3.92M	-2.26M	-2.02M	-37.12M
Other Non-Cash Items	-437K	-445K	-144K	-2.14M	-5.04M	2.88M	-43.22M	6M
Deferred Income Tax	n/a	n/a	n/a	n/a	-1.5M	-7.7M	-42.4M	17.82M
Change in Working Capital	-64K	176K	1.98M	-1.18M	-8.16M	-6.96M	-19.6M	-61.66M
Operating Cash Flow	-1.52M	-1.74M	-218K	-4.63M	-31.37M	-65.59M	-145.94M	-170.24M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	-118K	-915K	-3.15M
Cash Acquisitions	n/a	n/a	n/a	n/a	7.8M	28.07M	-4M	3.26M
Purchase of Investments	-18.59M	n/a	n/a	n/a	n/a	-103.06M	n/a	-84.26M
Sales Maturities Of Investments	6M	n/a	n/a	n/a	51.5M	52.5M	n/a	84.16M
Other Investing Acitivies	139K	445K	144K	2.14M	10.53M	28.07M	581.81M	-3.26M
Investing Cash Flow	-12.45M	445K	144K	2.14M	69.83M	-22.6M	576.89M	-3.26M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-145K	n/a	6.92M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	-26.7M	n/a	-140M	n/a
Other Financial Acitivies	521K	6.53M	239K	-56K	-15.84M	14.63M	-219.04M	9.42M
Financial Cash Flow	521K	6.53M	239K	-56K	-42.54M	14.63M	-359.04M	9.42M
Net Cash Flow	-13.45M	5.24M	165K	-2.54M	-4.08M	-73.55M	71.92M	-164.08M
Free Cash Flow	-1.52M	-1.74M	-218K	-4.63M	-31.37M	-65.71M	-146.85M	-173.4M